A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
Clinical trial NCT04300114 · TERMINATED
Trial details
- NCT number
- NCT04300114
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2022-02-18
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.